Louis G. Van Horn

Insider Reports History

Entity
Individual
Location
C/O Cingulate Therapeutics, 1901 W. 47 Th Place, Third Floor, Kansas City, KS
Signature
/s/ Jeff Bennett, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Louis G. Van Horn:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cingulate Inc. EVP and CFO Common Stock 142K $94.8K $0.67 Mar 14, 2022 By Louis G. Van Horn Trust, 12/23/19
Cingulate Inc. EVP and CFO Common Stock 15K $10K $0.67 Mar 14, 2022 Direct
Cingulate Inc. EVP and CFO Stock Option (right to Buy) 50K Feb 28, 2023 Direct

Insider Reports Filed by Louis G. Van Horn

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CING Cingulate Inc. Feb 28, 2023 1 $0 4 Mar 8, 2023 EVP and CFO
CING Cingulate Inc. Mar 14, 2022 1 $20K 4 Mar 16, 2022 EVP and CFO
CING Cingulate Inc. Feb 25, 2022 1 $0 4 Mar 1, 2022 EVP and CFO
CING Cingulate Inc. Dec 7, 2021 1 $0 4 Dec 9, 2021 EVP and CFO
CING Cingulate Inc. Dec 7, 2021 0 $0 3 Dec 7, 2021 EVP & Chief Financial Officer